ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram

International Journal of Legal Medicine

Volumn 127, Issue 3, 2013, Pages 579-586

  Karlsson, L ^a   Green, H ^a,b,c   Zackrisson, A L ^c   Bengtsson, F ^a   Jakobsen Falk, I ^a   Carlsson, B ^a   Ahlner, J ^a,c   Kugelberg, F C ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c National Board of Forensic Medicine   (Sweden)

Author keywords

ABCB1; Citalopram; Forensic material; Genotype; Postmortem; Venlafaxine

Indexed keywords

ABCB1 PROTEIN, HUMAN; ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXANOL DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; AUTOPSY; CASE CONTROL STUDY; DRUG OVERDOSE; FEMALE; FORENSIC GENETICS; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; VERY ELDERLY; ARTICLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTOPSY; CASE-CONTROL STUDIES; CITALOPRAM; CYCLOHEXANOLS; DRUG OVERDOSE; FEMALE; FORENSIC GENETICS; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; P-GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 84877873187     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-013-0849-0     Document Type: Article

References (53)

1. Ahlner J, Zackrisson AL, Lindblom B, Bertilsson L (2010) CYP2D6, serotonin and suicide. Pharmacogenomics 11:903-905
2. Andresen H, Augustin C, Streichert T (2012) Toxicogenetics-cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam. Int J Legal Med. doi: 10.1007/s00414-012-0759-6
3. Musshoff F, Stamer UM, Madea B (2010) Pharmacogenetics and forensic toxicology. Forensic Sci Int 203:53-62
4. Sajantila A, Palo JU, Ojanpera I, Davis C, Budowle B (2010) Pharmacogenetics in medico-legal context. Forensic Sci Int 203:44-52
5. Druid H, Holmgren P, Carlsson B, Ahlner J (1999) Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results. Forensic Sci Int 99:25-34
6. Holmgren P, Carlsson B, Zackrisson AL, Lindblom B, Dahl ML, Scordo MG, Druid H, Ahlner J (2004) Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYP2D6 and CYP2C19. J Anal Toxicol 28:94-104
7. Kingbäck M, Karlsson L, Zackrisson AL, Carlsson B, Josefsson M, Bengtsson F, Ahlner J, Kugelberg FC (2012) Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood. Forensic Sci Int 214:124-134
8. Koski A, Sistonen J, Ojanpera I, Gergov M, Vuori E, Sajantila A (2006) CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies. Forensic Sci Int 158:177-183
9. Levo A, Koski A, Ojanpera I, Vuori E, Sajantila A (2003) Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. Forensic Sci Int 135:9-15
10. Wong SH, Wagner MA, Jentzen JM, Schur C, Bjerke J, Gock SB, Chang CC (2003) Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity? J Forensic Sci 48:1406-1415
11. Zackrisson AL, Lindblom B, Ahlner J (2010) High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases. Clin Pharmacol Ther 88:354-359
12. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 86:695-698
13. Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E et al (2005) The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos 33:165-174
14. Karlsson L, Hiemke C, Carlsson B, Josefsson M, Ahlner J, Bengtsson F, Schmitt U, Kugelberg FC (2011) Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model. Psychopharmacology (Berl) 215:367-377
15. Karlsson L, Schmitt U, Josefsson M, Carlsson B, Ahlner J, Bengtsson F, Kugelberg FC, Hiemke C (2010) Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein. Eur Neuropsychopharmacol 20:632-640
16. Kirschbaum KM, Henken S, Hiemke C, Schmitt U (2008) Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice. Behav Brain Res 188:298-303
17. Uhr M, Grauer MT (2003) abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. J Psychiatr Res 37:179-185
18. Uhr M, Grauer MT, Holsboer F (2003) Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry 54:840-846
19. Uhr M, Grauer MT, Yassouridis A, Ebinger M (2007) Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. J Psychiatr Res 41:179-188
20. Uhr M, Steckler T, Yassouridis A, Holsboer F (2000) Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 22:380-387
21. Vetulani J, Nalepa I (2000) Antidepressants: past, present and future. Eur J Pharmacol 405:351-363
22. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB (1987) Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. Hum Genet 77:142-144
23. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97:3473-3478
24. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70:189-199
25. Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, Takahashi M, Kurata Y, Kigawa J, Higuchi S, Terakawa N, Otsubo K (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297:1137-1143
26. Evans WE, McLeod HL (2003) Pharmacogenomics - drug disposition, drug targets, and side effects. N Engl J Med 348:538-549
27. Marzolini C, Paus E, Buclin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13-33
28. Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, Dose T, Ebinger M, Rosenhagen M, Kohli M, Kloiber S, Salyakina D, Bettecken T, Specht M, Putz B, Binder EB, Muller-Myhsok B, Holsboer F (2008) Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57:203-209
29. Bozina N, Kuzman MR, Medved V, Jovanovic N, Sertic J, Hotujac L (2008) Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients. J Psychiatr Res 42:89-97
30. Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y, Hosoi Y, Takekita Y, Mandelli L, Azuma J, Kinoshita T (2008) ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:398-404
31. Sarginson JE, Lazzeroni LC, Ryan HS, Ershoff BD, Schatzberg AF, Murphy GM Jr (2010) ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenet Genomics 20:467-475
32. Buchard A, Linnet K, Johansen SS, Munkholm J, Fregerslev M, Morling N (2010) Postmortem blood concentrations of R- and S-enantiomers of methadone and EDDP in drug users: influence of co-medication and p-glycoprotein genotype. J Forensic Sci 55:457-463
33. Neuvonen AM, Palo JU, Sajantila A (2011) Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users. Int J Legal Med 125:265-269
34. Drummer OH (2007) Post-mortem toxicology. Forensic Sci Int 165:199-203
35. Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79-87
36. Jones AW, Schuberth J (1989) Computer-aided headspace gas chromatography applied to blood-alcohol analysis: importance of online process control. J Forensic Sci 34:1116-1127
37. Endres CJ, Hsiao P, Chung FS, Unadkat JD (2006) The role of transporters in drug interactions. Eur J Pharm Sci 27:501-517
38. Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, Bertschy G (2008) CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response. Ther Drug Monit 30:474-482
39. Laika B, Leucht S, Steimer W (2006) ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline. Clin Chem 52:893-895
40. Mihaljevic Peles A, Bozina N, Sagud M, Rojnic Kuzman M, Lovric M (2008) MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:1439-1444
41. Perlis RH, Fijal B, Dharia S, Heinloth AN, Houston JP (2010) Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients. Biol Psychiatry 67:1110-1113
42. Lin KM, Chiu YF, Tsai IJ, Chen CH, Shen WW, Liu SC, Lu SC, Liu CY, Hsiao MC, Tang HS, Liu SI, Chang LH, Wu CS, Tsou HH, Tsai MH, Chen CY, Wang SM, Kuo HW, Hsu YT, Liu YL (2011) ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment. Pharmacogenet Genomics 21:163-170
43. Nikisch G, Eap CB, Baumann P (2008) Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Pharmacol Res 58:344-347
44. Menu P, Gressier F, Verstuyft C, Hardy P, Becquemont L, Corruble E (2009) Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study. Neuropsychobiology 62:193-197
45. Peters EJ, Slager SL, Kraft JB, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP (2008) Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PLoS One 3:e1872
46. Buckley NA, McManus PR (2002) Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 325:1332-1333
47. Jönsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992-2002. Forensic Sci Int 143:53-59
48. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN (2004) Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 42:67-71
49. Whyte IM, Dawson AH, Buckley NA (2003) Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 96:369-374
50. Launiainen T, Rasanen I, Vuori E, Ojanpera I (2011) Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions. Int J Legal Med 125:349-538
51. Launiainen T, Vuori E, Ojanpera I (2009) Prevalence of adverse drug combinations in a large post-mortem toxicology database. Int J Legal Med 123:109-115
52. Jones AW, Kugelberg FC, Holmgren A, Ahlner J (2011) Drug poisoning deaths in Sweden show a predominance of ethanol in mono-intoxications, adverse drug-alcohol interactions and poly-drug use. Forensic Sci Int 206:43-51
53. Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344-348